{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:47:40Z","timestamp":1789015660704,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005690","name":"Universit\u00e4t des Saarlandes","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005690","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although a pivotal role of microRNA (miRNA, miR) in the pathogenesis of Huntington\u2019s disease (HD) is increasingly recognized, the molecular functions of miRNAs in the pathomechanisms of HD await further elucidation. One of the miRNAs that have been associated with HD is miR-34a-5p, which was deregulated in the mouse R6\/2 model and in human HD brain tissues.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The aim of our study was to demonstrate interactions between miR-34a-5p and HD associated genes. By computational means we predicted 12 801 potential target genes of miR-34a-5p. An in-silico pathway analysis revealed 22 potential miR-34a-5p target genes in the KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway \u201cHuntington\u2019s disease\u201d.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Using our high-throughput miRNA interaction reporter assay (HiTmIR) we identified <jats:italic>NDUFA9, TAF4B, NRF1, POLR2J2, DNALI1, HIP1, TGM2<\/jats:italic> and <jats:italic>POLR2G<\/jats:italic> as direct miR-34a-5p target genes. Direct binding of miR-34a-5p to target sites in the 3\u2019UTRs of <jats:italic>TAF4B, NDUFA9, HIP1<\/jats:italic> and <jats:italic>NRF1<\/jats:italic> was verified by a mutagenesis HiTmIR assay and by determining endogenous protein levels for HIP1 and NDUFA9<jats:italic>.<\/jats:italic> STRING (Search Tool for the Retrieval of Interacting Genes\/Proteins) analysis identified protein\u2013protein interaction networks associated with HD like \u201cGlutamine Receptor Signaling Pathway\u201d and \u201cCalcium Ion Transmembrane Import Into Cytosol\u201d.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study demonstrates multiple interactions between miR-34a-5p and HD associated target genes and thereby lays the ground for future therapeutic interventions using this miRNA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10020-023-00640-7","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T11:07:57Z","timestamp":1680520077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["miR-34a-5p as molecular hub of pathomechanisms in Huntington\u2019s disease"],"prefix":"10.1186","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9361-8106","authenticated-orcid":false,"given":"Martin","family":"Hart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Diener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Lunkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Rheinheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Krammes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckart","family":"Meese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"issue":"3","key":"640_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1261\/rna.2183803","volume":"9","author":"V Ambros","year":"2003","unstructured":"Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, Chen X, et al. A uniform system for microRNA annotation. RNA. 2003;9(3):277\u20139.","journal-title":"RNA"},{"issue":"2","key":"640_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4161\/rna.4.2.4640","volume":"4","author":"M Beitzinger","year":"2007","unstructured":"Beitzinger M, Peters L, Zhu JY, Kremmer E, Meister G. Identification of human microRNA targets from isolated argonaute protein complexes. RNA Biol. 2007;4(2):76\u201384.","journal-title":"RNA Biol"},{"issue":"4","key":"640_CR3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.bbrc.2015.08.090","volume":"465","author":"S Bucha","year":"2015","unstructured":"Bucha S, Mukhopadhyay D, Bhattacharyya NP. Regulation of mitochondrial morphology and cell cycle by microRNA-214 targeting Mitofusin2. Biochem Biophys Res Commun. 2015;465(4):797\u2013802.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"640_CR4","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1007\/s00415-013-6900-8","volume":"260","author":"LF Cardo","year":"2013","unstructured":"Cardo LF, Coto E, de Mena L, Ribacoba R, Moris G, Menendez M, et al. Profile of microRNAs in the plasma of Parkinson\u2019s disease patients and healthy controls. J Neurol. 2013;260(5):1420\u20132.","journal-title":"J Neurol"},{"issue":"12","key":"640_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo E, Zuccato C, Tartari M. Normal huntingtin function: an alternative approach to Huntington\u2019s disease. Nat Rev Neurosci. 2005;6(12):919\u201330.","journal-title":"Nat Rev Neurosci"},{"issue":"22","key":"640_CR6","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1016\/j.febslet.2006.08.076","volume":"580","author":"SA Choi","year":"2006","unstructured":"Choi SA, Kim SJ, Chung KC. Huntingtin-interacting protein 1-mediated neuronal cell death occurs through intrinsic apoptotic pathways and mitochondrial alterations. FEBS Lett. 2006;580(22):5275\u201382.","journal-title":"FEBS Lett"},{"issue":"4","key":"640_CR7","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.bbrc.2016.08.106","volume":"483","author":"M Czeredys","year":"2017","unstructured":"Czeredys M, Maciag F, Methner A, Kuznicki J. Tetrahydrocarbazoles decrease elevated SOCE in medium spiny neurons from transgenic YAC128 mice, a model of Huntington\u2019s disease. Biochem Biophys Res Commun. 2017;483(4):1194\u2013205.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"640_CR8","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41419-018-1050-7","volume":"9","author":"C Diener","year":"2018","unstructured":"Diener C, Hart M, Alansary D, Poth V, Walch-Ruckheim B, Menegatti J, et al. Modulation of intracellular calcium signaling by microRNA-34a-5p. Cell Death Dis. 2018;9(10):1008.","journal-title":"Cell Death Dis"},{"issue":"8","key":"640_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nmeth.3485","volume":"12","author":"H Dweep","year":"2015","unstructured":"Dweep H, Gretz N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods. 2015;12(8):697.","journal-title":"Nat Methods"},{"issue":"46","key":"640_CR10","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1038\/sj.onc.1209909","volume":"25","author":"BM Engels","year":"2006","unstructured":"Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene. 2006;25(46):6163\u20139.","journal-title":"Oncogene"},{"issue":"W1","key":"640_CR11","doi-asserted-by":"publisher","first-page":"W515","DOI":"10.1093\/nar\/gkaa306","volume":"48","author":"N Gerstner","year":"2020","unstructured":"Gerstner N, Kehl T, Lenhof K, Muller A, Mayer C, Eckhart L, et al. GeneTrail 3: advanced high-throughput enrichment analysis. Nucleic Acids Res. 2020;48(W1):W515\u201320.","journal-title":"Nucleic Acids Res"},{"issue":"52","key":"640_CR12","doi-asserted-by":"publisher","first-page":"41299","DOI":"10.1074\/jbc.M008408200","volume":"275","author":"AS Hackam","year":"2000","unstructured":"Hackam AS, Yassa AS, Singaraja R, Metzler M, Gutekunst CA, Gan L, et al. Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain. J Biol Chem. 2000;275(52):41299\u2013308.","journal-title":"J Biol Chem"},{"issue":"23","key":"640_CR13","doi-asserted-by":"publisher","first-page":"34288","DOI":"10.18632\/oncotarget.9103","volume":"7","author":"M Hart","year":"2016","unstructured":"Hart M, Rheinheimer S, Leidinger P, Backes C, Menegatti J, Fehlmann T, et al. Identification of miR-34a-target interactions by a combined network based and experimental approach. Oncotarget. 2016;7(23):34288\u201399.","journal-title":"Oncotarget"},{"issue":"6","key":"640_CR14","first-page":"819","volume":"15","author":"M Hart","year":"2018","unstructured":"Hart M, Kern F, Backes C, Rheinheimer S, Fehlmann T, Keller A, et al. The deterministic role of 5-mers in microRNA-gene targeting. RNA Biol. 2018;15(6):819\u201325.","journal-title":"RNA Biol"},{"issue":"6","key":"640_CR15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, et al. Regional and cellular gene expression changes in human Huntington\u2019s disease brain. Hum Mol Genet. 2006;15(6):965\u201377.","journal-title":"Hum Mol Genet"},{"key":"640_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12920-015-0083-3","volume":"8","author":"AG Hoss","year":"2015","unstructured":"Hoss AG, Labadorf A, Latourelle JC, Kartha VK, Hadzi TC, Gusella JF, et al. miR-10b-5p expression in Huntington\u2019s disease brain relates to age of onset and the extent of striatal involvement. BMC Med Genomics. 2015;8:10.","journal-title":"BMC Med Genomics"},{"issue":"D1","key":"640_CR17","first-page":"D148","volume":"48","author":"HY Huang","year":"2020","unstructured":"Huang HY, Lin YC, Li J, Huang KY, Shrestha S, Hong HC, et al. miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database. Nucleic Acids Res. 2020;48(D1):D148\u201354.","journal-title":"Nucleic Acids Res"},{"key":"640_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev.biochem.73.011303.073706","volume":"73","author":"X Jiang","year":"2004","unstructured":"Jiang X, Wang X. Cytochrome C-mediated apoptosis. Annu Rev Biochem. 2004;73:87\u2013106.","journal-title":"Annu Rev Biochem"},{"issue":"7","key":"640_CR19","doi-asserted-by":"publisher","first-page":"a024240","DOI":"10.1101\/cshperspect.a024240","volume":"7","author":"M Jimenez-Sanchez","year":"2017","unstructured":"Jimenez-Sanchez M, Licitra F, Underwood BR, Rubinsztein DC. Huntington\u2019s disease: mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harb Perspect Med. 2017;7(7):a024240.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"640_CR20","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","volume":"29","author":"R Johnson","year":"2008","unstructured":"Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E, Buckley NJ. A microRNA-based gene dysregulation pathway in Huntington\u2019s disease. Neurobiol Dis. 2008;29(3):438\u201345.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"640_CR21","doi-asserted-by":"publisher","first-page":"e54222","DOI":"10.1371\/journal.pone.0054222","volume":"8","author":"A Jovicic","year":"2013","unstructured":"Jovicic A, Zaldivar Jolissaint JF, Moser R, Silva Santos Mde F, Luthi-Carter R. MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington\u2019s disease-related mechanisms. PLoS ONE. 2013;8(1):e54222.","journal-title":"PLoS ONE"},{"key":"640_CR22","first-page":"103","volume":"4","author":"RK Kalathur","year":"2015","unstructured":"Kalathur RK, Giner-Lamia J, Machado S, Barata T, Ayasolla KR, Futschik ME. The unfolded protein response and its potential role in Huntington\u2019s disease elucidated by a systems biology approach. Fres. 2015;4:103.","journal-title":"Fres"},{"issue":"1","key":"640_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/nar\/gkaa1161","volume":"49","author":"F Kern","year":"2021","unstructured":"Kern F, Krammes L, Danz K, Diener C, Kehl T, Kuchler O, et al. Validation of human microRNA target pathways enables evaluation of target prediction tools. Nucleic Acids Res. 2021;49(1):127\u201344.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"640_CR24","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3390\/cells9061442","volume":"9","author":"L Krammes","year":"2020","unstructured":"Krammes L, Hart M, Rheinheimer S, Diener C, Menegatti J, Grasser F, et al. Induction of the endoplasmic-reticulum-stress response: MicroRNA-34a targeting of the IRE1alpha-branch. Cells. 2020;9(6):1442.","journal-title":"Cells"},{"key":"640_CR25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3389\/fnmol.2017.00430","volume":"10","author":"A Labadorf","year":"2017","unstructured":"Labadorf A, Choi SH, Myers RH. Evidence for a pan-neurodegenerative disease response in Huntington\u2019s and Parkinson\u2019s disease expression profiles. Front Mol Neurosci. 2017;10:430.","journal-title":"Front Mol Neurosci"},{"issue":"7","key":"640_CR26","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/gb-2013-14-7-r78","volume":"14","author":"P Leidinger","year":"2013","unstructured":"Leidinger P, Backes C, Deutscher S, Schmitt K, Mueller SC, Frese K, et al. A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 2013;14(7):R78.","journal-title":"Genome Biol"},{"issue":"16","key":"640_CR27","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1093\/hmg\/ddw187","volume":"25","author":"L Lin","year":"2016","unstructured":"Lin L, Park JW, Ramachandran S, Zhang Y, Tseng YT, Shen S, et al. Transcriptome sequencing reveals aberrant alternative splicing in Huntington\u2019s disease. Hum Mol Genet. 2016;25(16):3454\u201366.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"640_CR28","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jmg.30.12.982","volume":"30","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Barnes G, Srinidhi J, Duyao MP, Ambrose CM, Myers RH, et al. Gametic but not somatic instability of CAG repeat length in Huntington\u2019s disease. J Med Genet. 1993;30(12):982\u20136.","journal-title":"J Med Genet"},{"issue":"4","key":"640_CR29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3233\/JHD-150172","volume":"4","author":"AC McCourt","year":"2015","unstructured":"McCourt AC, Parker J, Silajdzic E, Haider S, Sethi H, Tabrizi SJ, et al. Analysis of white adipose tissue gene expression reveals CREB1 pathway altered in Huntington\u2019s disease. J Huntington\u2019s Dis. 2015;4(4):371\u201382.","journal-title":"J Huntington\u2019s Dis"},{"issue":"9","key":"640_CR30","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1523\/JNEUROSCI.5175-06.2007","volume":"27","author":"M Metzler","year":"2007","unstructured":"Metzler M, Gan L, Wong TP, Liu L, Helm J, Liu L, et al. NMDA receptor function and NMDA receptor-dependent phosphorylation of huntingtin is altered by the endocytic protein HIP1. J Neurosci. 2007;27(9):2298\u2013308.","journal-title":"J Neurosci"},{"issue":"12","key":"640_CR31","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1261\/rna.2384610","volume":"16","author":"F Moretti","year":"2010","unstructured":"Moretti F, Thermann R, Hentze MW. Mechanism of translational regulation by miR-2 from sites in the 5\u2019 untranslated region or the open reading frame. RNA. 2010;16(12):2493\u2013502.","journal-title":"RNA"},{"issue":"53","key":"640_CR32","doi-asserted-by":"publisher","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","volume":"28","author":"AN Packer","year":"2008","unstructured":"Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL. The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington\u2019s disease. J Neurosci. 2008;28(53):14341\u20136.","journal-title":"J Neurosci"},{"key":"640_CR33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mcn.2017.12.009","volume":"88","author":"RH Reynolds","year":"2018","unstructured":"Reynolds RH, Petersen MH, Willert CW, Heinrich M, Nymann N, Dall M, et al. Perturbations in the p53\/miR-34a\/SIRT1 pathway in the R6\/2 Huntington\u2019s disease model. Mol Cell Neurosci. 2018;88:118\u201329.","journal-title":"Mol Cell Neurosci"},{"key":"640_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.nbd.2015.10.016","volume":"86","author":"AB Rocher","year":"2016","unstructured":"Rocher AB, Gubellini P, Merienne N, Boussicault L, Petit F, Gipchtein P, et al. Synaptic scaling up in medium spiny neurons of aged BACHD mice: a slow-progression model of Huntington\u2019s disease. Neurobiol Dis. 2016;86:131\u20139.","journal-title":"Neurobiol Dis"},{"issue":"D1","key":"640_CR35","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"key":"640_CR36","doi-asserted-by":"crossref","unstructured":"The Huntington\u2019s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell. 1993;72(6):971\u201383.","DOI":"10.1016\/0092-8674(93)90585-E"},{"issue":"4","key":"640_CR37","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.bbrc.2013.12.114","volume":"443","author":"M Ueda","year":"2014","unstructured":"Ueda M, Li S, Itoh M, Hayakawa-Yano Y, Wang MX, Hayakawa M, et al. Polyglutamine expansion disturbs the endoplasmic reticulum formation, leading to caspase-7 activation through Bax. Biochem Biophys Res Commun. 2014;443(4):1232\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"640_CR38","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.chembiol.2011.04.012","volume":"18","author":"J Wu","year":"2011","unstructured":"Wu J, Shih HP, Vigont V, Hrdlicka L, Diggins L, Singh C, et al. Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington\u2019s disease treatment. Chem Biol. 2011;18(6):777\u201393.","journal-title":"Chem Biol"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-023-00640-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T11:13:32Z","timestamp":1680520412000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-023-00640-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["640"],"URL":"https:\/\/doi.org\/10.1186\/s10020-023-00640-7","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"14 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}